Porcine reproductive and respiratory syndrome virus (PRRSV) MN-1b strain open reading frame 4 (ORF4) has been cloned, sequenced, and expressed in Escherichia coli. The homologies of nucleotide and amino acid sequences between MN-1b (US isolate) and LV (European isolate) are 69% and 64%, respectively. The data also showed that ORF4 of MN-lb is 36 bases shorter than that of LV. Western blot analysis of expressed recombinant ORF4 protein reacted with 65% (26/40) of PRRSV-infected pig sera tested. These results demonstrated that ORF4 of PRRSV may not be a well-conserved region.
compared with those of the PRRSV LV strain (European isolate). The expressed recombinant ORF4 protein also was characterized by its interaction with a panel of PRRSV-infected pig sera.
Materials and methods
Virus, cell line, and serum samples. The PRRSV MN-1b strain was grown in the MARC-145 cell line. This virus has been propagated in the MARC-145 cell line for many passages, and the cell culture condition and virus infectivity have been described. 7 This cell line is highly permissive to the US PRRSV isolates and produces a high-titer virus. A panel of 49 sera were included in the study. Among these, 40 were from PRRSV-infected pigs collected from 4 different midwestern swine farms, 8 were from uninfected animals collected from 2 different midwestem farms, and 1 was from a pig immunized with PRRSV MN-1b. The status of the positive sera was confirmed by an indirect fluorescent antibody (IFA) test, and their titers were from 1:16 to 1:1,024. 17 PRRS viral RNA polymerase chain reaction (PCR). Oligonucleotide primers were synthesized according to nucleotide sequence information from the LV. Primer 1 (5' TT GGA TCC ATG GCT GCG GCC ACT CTT) and primer 2 (5' TT GAA TTC TCA TAT TGC CAA GAG AAT) were specific primers for the LV ORF4 region. The BamHI and EcoRI restriction sites were incorporated at the 5' end of the primers to facilitate cloning. To extract viral RNA, 100 µl of virus supernatant from the MN-1b PRRSV-infected MARC-145 cell line were used. The viral RNAs were used as templates and subjected to RNA PCR in an automated DNA thermal cycler. a Bacterial strain and plasmid. Escherichia coli strain JM105 was used as a host bacteria for cloning and expression. The plasmid pGex2T b was used as a starting material for constructing an expression vector. Following amplification, a PCR product of the appropriate size was cloned into the pGex2T. The resulting recombinant plasmid for the expression of ORF4 fusion protein was pGex2T-ORF4. The procedures for induced expression and preparation of bacterial lysates for gel analysis and partial purification of the recombinant protein have been previously described in detail. 8 DNA sequencing. The pGex2T-ORF4 protein was prepared for nucleotide sequencing with the 5' and 3' pGex2T sequencing primers, which were hybridized at positions 869-891 and 998-1,020 on the pGex2T vectors, respectively. 4 Oligonucleotide primers were synthesized on an automated DNA synthesizer. c Nucleotide sequencing was done by a DNA sequencing system, d and the sequencing reagents were used according to the manufacturer's recommendations. Both strands of the ORF4 insert were sequenced at least twice.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot assays. SDS-PAGE and western blots were performed using the standard protocols. 9,14
Results
Sequence analysis and comparisons with the LV sequence of ORF4. The MN-1b ORF4 gene is 513 bases long. The complete nucleotide sequence of this gene and deduced amino acid sequence have been determined and are shown in Fig. 1 . A comparison of the MN-lb with the LV ORF4 (549 base pair [bp]) sequence indicated that ORF4 of MN-1b is 36 bases shorter than the LV genome, and the nucleotide sequence homology between these 2 viruses is 69%. At the amino acid level, these 2 proteins only have 64% homology, and most of this divergence was located at the N-terminal of the protein (Fig. 2) . However, 4 po-tential N-linked glycosylation sites (ASN-X-Ser/Thr) were identical in both isolates (Fig. 1 ).
Bacterial expression of MN-1b ORF4 protein.
The 513-bp PCR products of MN-1b ORF4 were fused in sequence to encode the glutathione-S-transferase (GST) protein under the control of the Taq promoter of pGex2T. The construct pGex2T-ORF4 was used to transform E. coli JM105. The induced total cell lysates were found to encode a 45-kD fusion protein on Coomassie blue-stained gels, consistent with the precisely calculated molecular mass (GST 26 kD plus ORF4 19 kD; Fig. 3, lane 3) . Because this protein is not glycosylated in the bacterial expression system, the molecular weight reflects the amino acid backbone solely. This protein was not observed in bacteria, which contained the pGex2T control plasmid without insert (Fig.  3, lane 2) . The recombinant fusion protein could be enriched by 1 and 6 M urea and SDS buffer sequential extraction of the insoluble fraction of the induced bacterial cell lysates (Fig. 3, lane 4) .
Western blot analysis of the recombinant ORF4.
To determine whether the 45-kD recombinant protein produced by the E. coli bearing the ORF4 gene construct is recognized by antiserum directed against the MN-lb virus and field PRRSV-infected animals, the recombinant protein was subjected to western blot analysis. Serum from a MN-1b-immunized pig reacted their reactivity was tested with the MN-1b ORF4 recombinant protein in the western blot assay. Of these 40 sera, only 26 (65%) were scored positive by this assay, and the intensity of the reactive band on the strips did not correlate with the IFA titers. Among the 26 western blot-positive sera, positive individuals were randomly distributed among 4 pig herds studied. Representative blots are shown in Fig. 4 .
Discussion
The lack of an accessible established cell line permissive to PRRSV has been a major impediment to the progress in understanding the molecular biology of PRRSV and the role of individual proteins in infection and immunity. The development of the MARC-145 cell line, which is highly permissive to PRRSV and allows viral propagation in excess of up to 10 8 TCID 50 / ml, has greatly increased the capability to study this virus. One hundred microliters of viral culture medium from the MARC-145 cell line was enough to extract viral RNA, run RNA PCR, generate cDNA, and clone the ORF4 cDNA into a plasmid for nucleotide sequence analysis. Sequence data presented here demonstrated that there was a substantial genomic variation at the ORF4 gene between LV and MN-1b isolates of PRRSV.
To understand the difference in the interaction of MN-1b ORF4 recombinant protein with the pig host immune system after being infected with PRRSV, the ORF4 has been expressed. The pGex2T expression system used for this study produced an immunologically reactive ORF4 fusion protein. This fusion protein reacted with only 65% (26/40) of the PRRSV IFApositive pig sera. There are 3 possible explanations for the discrepancy between these 2 assay results. 1) The IFA test used virus-infected cells that contained a whole spectrum of viral proteins. The recombinant western blot assay only used the ORF4 protein. Thus, the serologic spectrum analyzed using the 2 methods were not necessarily the same. 2) The ORF4 of PRRSV may not be a well-conserved region, as compared with other ORFs, useful for antibody detection. MN-1b ORF4 had considerable sequence variability as compared with Lelystad ORF4. 3) When PRRSV infects eukaryotical cells, the ORF4 gene potentially has 4 sites for N-linked glycosylation. However, posttranslational processing in E. coli differs from that of eukaryotic cells so that some of the important epitopes of ORF4 produced in E. coli may lack the required biological activity.
When sera from these 4 swine herds were used in an MN-lb whole-virus lysate western blot assay, 4 protein bands (p 15, p 19, p29, and p42) were collectively identified on the strips. However, none of these protein bands were unanimously recognized by all sera. Specifically, for a given PRRSV protein band, in a random 10-40% of the sera the protein was not undetected (data not shown). These data are consistent with the recombinant ORF4 western blot results, which suggest that antigenic divergences exist among the US PRRSV strains. The data demonstrate the need to identify highly conserved homologous regions of the viral genome among strains before recombinant protein and molecular biological probes can be effectively applied as diagnostic procedures or as a purposed vaccine for PRRS.
